blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4338799

EP4338799 - TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  16.02.2024
Database last updated on 11.09.2024
Most recent event   Tooltip03.05.2024Publication of search reportpublished on 05.06.2024  [2024/23]
03.05.2024Change - classificationpublished on 05.06.2024  [2024/23]
03.05.2024Change - classificationpublished on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Regents of the University of Minnesota
600 McNamara Alumni Center
200 Oak Street SE
Minneapolis, MN 55455 / US
For all designated states
Intima Bioscience, Inc.
3 Columbus Circle
New York, New York 10019 / US
For all designated states
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
6011 Executive Boulevard Suite 325 MSC 7660
Bethesda, MD 20892-7660 / US
[2024/12]
Inventor(s)01 / MORIARITY, Branden
Shoreview, 55126-8516 / US
02 / WEBBER, Beau
Coon Rapids / US
03 / CHOUDHRY, Modassir
New York, 10019 / US
04 / ROSENBERG, Steven A.
Potomac, 20854 / US
05 / PALMER, Douglas C.
N. Bethesda, 20852 / US
06 / RESTIFO, Nicholas P.
Chevy Chase, 20815 / US
 [2024/12]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2024/12]
Application number, filing date23211578.218.10.2017
[2024/12]
Priority number, dateUS201662409651P18.10.2016         Original published format: US 201662409651 P
US201762452244P30.01.2017         Original published format: US 201762452244 P
[2024/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4338799
Date:20.03.2024
Language:EN
[2024/12]
Type: A3 Search report 
No.:EP4338799
Date:05.06.2024
Language:EN
[2024/23]
Search report(s)(Supplementary) European search report - dispatched on:EP07.05.2024
ClassificationIPC:A61K35/17, C12N15/113, C12N9/22, C12N5/0783, C07K14/47, C07K14/705, C07K14/715, C12N5/078, A61K39/00, A61P31/12, A61P35/00, A61P35/02
[2024/23]
CPC:
C12N15/113 (EP,US); A61P35/00 (EP,GB,US); A61K2239/31 (EP,GB,US);
A61K2239/38 (EP,GB,US); A61K2239/52 (EP,GB,US); A61K2239/57 (EP,GB,US);
A61K39/4611 (EP,GB,US); A61K39/4644 (EP,GB,US); A61K9/0019 (US);
A61K9/0053 (US); A61P31/00 (EP,US); A61P31/10 (GB);
A61P31/12 (EP); A61P35/02 (EP); C07K14/4703 (EP,US);
C07K14/70503 (EP,US); C07K14/7051 (US); C07K14/70521 (EP,US);
C07K14/7158 (EP,US); C12N15/79 (US); C12N15/902 (US);
C12N5/0634 (EP,GB,US); C12N5/0636 (EP,GB,US); C12N9/22 (EP,US);
A61K2300/00 (US); A61K45/06 (US); C12N2310/20 (EP,US);
C12N2510/00 (US) (-)
Former IPC [2024/12]A61P31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/12]
TitleGerman:TUMORINFILTRIERENDE LYMPHOZYTEN UND THERAPIEVERFAHREN[2024/12]
English:TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY[2024/12]
French:LYMPHOCYTES INFILTRANT LES TUMEURS ET PROCÉDÉS DE THÉRAPIE[2024/12]
Parent application(s)   TooltipEP17861792.4  / EP3529359
Fees paidRenewal fee
22.11.2023Renewal fee patent year 03
22.11.2023Renewal fee patent year 04
22.11.2023Renewal fee patent year 05
22.11.2023Renewal fee patent year 06
22.11.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2009220488  (GARDNER HUMPHREY [US]);
 [A]US2015259684  (CHURCH GEORGE M [US], et al);
 [Y]WO2015143328  (H LEE MOFFITT CANCER CT & RES [US], et al);
 [AP]US2017065636  (MORIARITY BRANDEN [US], et al);
by applicantUS6120766
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.